Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Dipna Pharmachem Ltd (543594)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543594 NSE: Trading | Small Cap | Dipna Pharmachem Share Price
₹4.56 -0.09 (-1.94%)
As on 11-Sep'26 16:59
Dipna Pharmachem Ltd (543594)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543594 NSE: Trading | Small Cap | Dipna Pharmachem Share Price
₹4.56 -0.09 (-1.94%)
As on 11-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹12 Cr.
Current Price
₹4.6
52-Week Low / High
₹4 / 25
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
40.3
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-23.99%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
9.13%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹26.3 Cr.
Face Value
₹10
All Time Low / High
₹3.90 / 27.61
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Dipna Pharmachem Ltd a good quality company?
Dipna Pharmachem Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Dipna Pharmachem Ltd performance compare with that of its Peers?
Revenue growth of Dipna Pharmachem Ltd vs industry peers?
Dipna Pharmachem Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Dipna Pharmachem Ltd?
Promoters hold 9.13% of the Dipna Pharmachem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Dipna Pharmachem Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -38.5% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dipna Pharmachem Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 7.2% | 8% | 5.4% | 3.5% | 18.2% | 9.2% | 7.2% | 7% | - |
| Value Creation Index ⓘ | -0.5 | -0.4 | -0.6 | -0.8 | 0.3 | -0.4 | -0.5 | -0.5 | - |
Growth Parameters ⓘ |
|||||||||
| Sales ⓘ | 16.6 | 20.2 | 30.5 | 31 | 72.8 | 99.9 | 164 | 125 | 129 |
| Sales YoY Gr. | - | 21.9% | 51.3% | 1.5% | 134.7% | 37.3% | 64.5% | -24% | - |
| Adj EPS ⓘ | 3.5 | 5 | 4.4 | 1.2 | 57.1 | 0.6 | 0.5 | 0.4 | 1 |
| YoY Gr. | - | 43.4% | -12.8% | -72.9% | 4736.4% | -98.9% | -28.6% | -8.9% | - |
| BVPS (₹) ⓘ | 22.3 | 23.9 | 26.8 | 28 | 85 | 16.7 | 15.6 | 16 | 16.8 |
| Adj Net Profit ⓘ | 0.1 | 0.1 | 0.1 | 0 | 1.2 | 0.9 | 1.1 | 1 | 3 |
| Cash Flow from Ops. ⓘ | 0 | 0 | -3.1 | -2.4 | 2.8 | -21 | -5.4 | -9.2 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | -3.1 | -5.1 | 3.6 | -0.8 | -3.6 | -1.9 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 32.5% | 19.7% | -24% | ||||
| Adj EPS ⓘ | NA | -37.7% | -80.7% | -8.9% | ||||
| BVPSⓘ | NA | -9.8% | -42.7% | 2.6% | ||||
| Share Price | - | - | -40.8% | -79% | ||||
Key Financial Parameters ⓘ
| Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 15.6 | 21.6 | 17.2 | 4.3 | 101 | 7 | 3.5 | 2.6 | 6.1 |
| Op. Profit Mgn % ⓘ | 2.4 | 2.9 | 1.6 | 1.3 | 3.1 | 2.4 | 2.1 | 3.1 | 9.7 |
| Net Profit Mgn % ⓘ | 0.4 | 0.5 | 0.3 | 0.1 | 1.6 | 0.9 | 0.7 | 0.8 | 2 |
| Debt to Equity ⓘ | 11.2 | 12.3 | 17.5 | 21.7 | 5.9 | 0.7 | 0.5 | 0.5 | 0.2 |
| Working Cap Days ⓘ | 0 | 223 | 192 | 252 | 152 | 197 | 212 | 367 | 3,682 |
| Cash Conv. Cycle ⓘ | 0 | 74 | 83 | 115 | 47 | 49 | 15 | -41 | 488 |
Valuation of Dipna Pharmachem - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Dipna Pharmachem Ltd FAQs
The current trading price of Dipna Pharmachem on 11-Sep-2026 16:59 is ₹4.56.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of Dipna Pharmachem stood at ₹11.99 Cr
The latest P/E ratio of Dipna Pharmachem as of 10-Sep-2026 is 4.55.
The latest P/B ratio of Dipna Pharmachem as of 10-Sep-2026 is 0.27.
The 52-week high of Dipna Pharmachem is ₹25.00 and the 52-week low is ₹3.90.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dipna Pharmachem is ₹129 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dipna Pharmachem Ltd is a below average quality company.
The key valuation ratios of Dipna Pharmachem Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dipna Pharmachem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Dipna Pharmachem Ltd
The company was originally incorporated as “Dipan Pharmachem Private Limited” under the provisions of Companies Act, 1956 vide Certificate of Incorporation dated July 19, 2011 bearing Corporate Identification Number issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, the name of company was changed to “Dipna Pharmachem Private Limited” and a fresh certificate of incorporation was issued by Registrar of Companies, Gujarat, Dadra and Nagar Havelli on March 29, 2012. After that, the Company was converted from Private limited to Public Limited company pursuant to a special resolution passed by shareholders at the EGM held on May 13, 2022 and consequently the name of Company was changed as “Dipna Pharmachem Limited” and a fresh certificate of incorporation was issued by the Registrar of Companies, Ahmedabad dated May 25, 2022.
The company is engaged in the trading and distribution of wide range of pharmaceutical raw material which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. Presently its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. Being a trading and distribution company, it has pan India market for its products. The company had also started the selling of chemicals on commission basis. In the financial year 2022, the company had earned commission income of Rs 127.50 lakh. The company is doing trading in Ahmedabad and surrounding area of Ahmedabad.
Business area of the company
Dipna Pharmachem is a trader, importer, and exporter in industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation since 2011. The company’s huge portfolio includes expertise for marketing and sourcing of industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation and intermediates, assistance in setting up contract manufacturing compliance for regulated, semi-regulated pharmaceutical companies with all the global benchmark parameters of leading certificates like WHO-GMP.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
